Literature DB >> 26261671

Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1: a case report and literature review.

Hidehiro Takei1, Emilie Rouah2, Meenakshi B Bhattacharjee3.   

Abstract

Pleomorphic xanthoastrocytoma (PXA) is an uncommon tumor of young adults that typically occurs supratentorially. It is generally considered to be a low-grade, circumscribed tumor that when treated by surgical resection has a relatively favorable outcome. Cases of cerebellar PXA are rare, and those associated with neurofibromatosis type 1 (NF1) are even less common, with only 2 cases reported to date. We present herein a third case of PXA-NF1 with unusual features. A 33-year-old woman presented with a history of headache. Her medical and family history was significant for NF1. Brain MRI revealed a 3.4 cm ill-defined lesion with a gyriform enhancing pattern in the left cerebellum, superficially mimicking Lhermitte-Duclos disease. The patient underwent a gross total resection of the lesion and had an unremarkable postoperative course. While the lesion had histological features typical of "pure" PXA (WHO grade II) it had an unusual growth pattern with thickening of the superficial cerebellar folia and predominant leptomeningeal involvement. No BRAF, IDH-1, or IDH-2 mutation was identified. Three months after surgery, local recurrence was detected, and the patient was treated with radiation therapy. One year after the first surgery, she underwent surgical resection of the recurrent/residual tumor. Histologically, the recurrent tumor showed very similar features to the initially resected tumor, with no anaplastic features. Most cerebellar PXAs have an indolent clinical behavior as do most cerebral PXAs. Whether co-existence of NF1 was a factor in altering the clinical course and biologic behavior of this patient's tumor is currently unknown.

Entities:  

Keywords:  Pleomorphic xanthoastrocytoma (PXA); cerebellum; neurofibromatosis type-1 (NF1); recurrence

Mesh:

Substances:

Year:  2015        PMID: 26261671      PMCID: PMC4526005     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Unique presentation of pleomorphic xanthoastrocytoma as a lytic skull lesion in an eight-year-old girl.

Authors:  Andrew Jea; John Ragheb; Glenn Morrison
Journal:  Pediatr Neurosurg       Date:  2002-11       Impact factor: 1.162

2.  Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

Authors:  Jean-Sébastien Guillamo; Alain Créange; Chantal Kalifa; Jacques Grill; Diana Rodriguez; François Doz; Sébastien Barbarot; Michel Zerah; Marc Sanson; Sylvie Bastuji-Garin; Pierre Wolkenstein
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

3.  Atypical pleomorphic xanthoastrocytoma.

Authors:  A Bucciero; M I De Caro; E Tedeschi; V De Stefano; M Bianco; A Soricelli; L Vizioli; A Cerillo
Journal:  J Neurosurg Sci       Date:  1998-09       Impact factor: 2.279

4.  Multicentric pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Case report and review of the literature.

Authors:  Stephan Saikali; Anne Le Strat; Anne Heckly; Nathalie Stock; Jean-Marie Scarabin; Abderrahmane Hamlat
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

5.  Pleomorphic xanthoastrocytoma with neurofibromatosis type 1: case report.

Authors:  O Kubo; A Sasahara; Y Tajika; H Kawamura; H Kawabatake; K Takakura
Journal:  Noshuyo Byori       Date:  1996-04

6.  Intrasellar pleomorphic xanthoastrocytoma: case report.

Authors:  Kazunori Arita; Kaoru Kurisu; Atsushi Tominaga; Kazuhiko Sugiyama; Masayuki Sumida; Takanori Hirose
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

7.  Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report.

Authors:  Hidehiro Takei; Robert Dauser; Jack Su; Murali Chintagumpala; Meenakshi B Bhattacharjee; Jeremy Jones; Adekunle M Adesina
Journal:  J Neurosurg       Date:  2007-08       Impact factor: 5.115

8.  Pleomorphic xanthoastrocytoma associated with von Recklinghausen neurofibromatosis.

Authors:  M M Ozek; A Sav; M N Pamir; A F Ozer; E Ozek; C Erzen
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

9.  Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1.

Authors:  M J Naidich; M T Walker; N R Gottardi-Littell; G Han; J P Chandler
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

Review 10.  Cerebellar pleomorphic xanthoastrocytoma: case report and literature review.

Authors:  Abderrahmane Hamlat; Anne Le Strat; Yvon Guegan; Mohamed Ben-Hassel; Stephan Saikali
Journal:  Surg Neurol       Date:  2007-05-29
View more
  5 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

2.  Anaplastic Pleomorphic Xanthoastrocytoma in a Case of Neurofibromatosis Type 1: A Case Report.

Authors:  K Thara; Reetika Sharma; G Thiagarajan; Anita Ramdas; Renu Gboy Varghese
Journal:  J Clin Diagn Res       Date:  2017-04-01

3.  Management and outcome of unusual pediatric brain tumors: challenges experienced at a tertiary care center of a developing country.

Authors:  Anand Kumar Das; Suraj Kant Mani; Saraj Kumar Singh; Subhash Kumar
Journal:  Childs Nerv Syst       Date:  2022-10-06       Impact factor: 1.532

4.  Pleomorphic Xanthoastrocytoma of the Pineal Region in a Pediatric Patient With Neurofibromatosis Type 1.

Authors:  Joshua A Hanna; Mansour Mathkour; Edna E Gouveia; JonMark Lane; Lauren Boehm; Joseph R Keen; Erin E Biro; Olawale A Sulaiman; Cuong J Bui
Journal:  Ochsner J       Date:  2020

5.  Demography, Pattern of Care, and Survival in Patients with Xanthoastrocytoma: A Systematic Review and Individual Patient Data Analysis of 325 Cases.

Authors:  Supriya Mallick; Prashanth Giridhar; Rony Benson; Wineeta Melgandi; Goura Kishor Rath
Journal:  J Neurosci Rural Pract       Date:  2019-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.